Financial comparisons Celltrion, Inc.

Equities

End-of-day quote Korea S.E. Other stock markets 13/02/2026			5-day change	1st Jan Change
238,000.00 ^KRW	-0.21%		+4.62%	+31.49%

02-05	CVS Health to drop Amgen and Lilly's bone disease treatments from some drug lists (February 5)	RE
01-30	Celltrion Launches Autoimmune Drug Aptozma in Europe	MT

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Revenues (Y-1)	Net Margin (Y-1)	EBIT Margin (Y-1)	ROE (Y-1)	ROA (Y-1)	Leverage (Y-1)
CELLTRION, INC.	2.41B	11.88%	13.83%	2.46%	2.14%	1.28x
LONZA GROUP AG	7.25B	9.67%	17.9%	6.77%	3.48%	1.5x
BEONE MEDICINES AG	3.81B	-16.92%	-14.91%	-18.77%	-11%	4.06x
IQVIA HOLDINGS INC.	15.4B	8.91%	20.12%	33.53%	5.12%	3.33x
EUROFINS SCIENTIFIC SE	7.2B	5.84%	14.63%	7.8%	3.73%	1.93x
ASCENDIS PHARMA A/S	846M	-31.67%	-18.92%	-	-	1.57x
IONIS PHARMACEUTICALS, INC.	705M	-64.4%	-67.38%	-93.12%	-15.15%	2.26x
MEDPACE HOLDINGS, INC.	2.53B	17.83%	20.93%	70.23%	22.13%	-0.89x
QIAGEN N.V.	1.98B	4.23%	28.66%	13.31%	8.32%	0.34x
ABIVAX	12.94M	-1,409.6%	-1,383.2%	-148.95%	-	0.4x
BIO-TECHNE CORPORATION	1.22B	6.02%	31.45%	15.37%	11.65%	0.43x
TEMPUS AI, INC.	693M	-107.63%	-20.47%	-	-25.37%	0.13x
PRAXIS PRECISION MEDICINES, INC.	8.55M	-2,137.48%	-2,340.29%	-70.98%	-64.03%	1.96x
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.	4.05B	0.25%	19.9%	15.1%	6.78%	2.05x
PHARMARON BEIJING CO., LTD.	1.68B	14.61%	17.14%	13.7%	7.12%	1.33x
HANGZHOU TIGERMED CONSULTING CO., LTD	905M	6.14%	7.92%	1.94%	1.39%	0.27x
ICON PUBLIC LIMITED COMPANY	8.28B	9.56%	19.29%	12.39%	6.87%	1.66x
KYMERA THERAPEUTICS, INC.	47.07M	-475.57%	-555.82%	-36.38%	-28.81%	3.35x
Average	3.28B	-230.46%	-232.73%	-10.97%	-4.1%	1.50x
Weighted average by Cap.	4.56B	-131.39%	-129.4%	-5.4%	-2.21%	1.84x